Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
APLP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GPAM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPCS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DEPTOR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LINC00900 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CTNND2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PNO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TSSK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ABCC4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EIF4E3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ERI2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SELT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDYL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NT5DC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MDGA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NCK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TSPAN12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BNIP3L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on